Post COVID-19 condition among individuals hospitalized during Wave 1 and Wave 2 at Mulago National Referral Hospital and Entebbe Regional Referral Hospital, Uganda, 2020-2021

Author:

Komakech Allan1,Juniour Edirisa Nsubuga1,Drazidio Judith2,Migamba Stella Martha1,Kadobera Daniel1,Bulage Lilian1,Kwesiga Benon1,Riolexus Alex Ario1

Affiliation:

1. Uganda National Institute of Public Health

2. Clarke International University

Abstract

Abstract Introduction: The presence of long-term symptoms among COVID-19 survivors is referred to as Post COVID-19 condition (PCC). In Uganda, the burden of PCC is unknown. We described the spectrum of and risk factors for PCC among persons hospitalized with COVID-19 to inform decision-making. Methods We conducted a retrospective cohort study among randomly-selected COVID-19 survivors hospitalized at Mulago and Entebbe Referral Hospitals during Wave 1 (October 2020-December 2020) and Wave 2 (May 2021-June 2021) of the pandemic in Uganda. A PCC case was defined as persistent, returning, or new COVID-19 symptoms occurring during the 4–12 weeks after onset for non-severe disease and during the 8–12 weeks from onset for severe disease, without an alternative diagnosis in a person with confirmed SARS-CoV-2 infection. Patients were contacted by phone, and risk factors for PCC were established using modified Poisson regression. Findings: Among 798 COVID-19 survivors (Wave 1: 391; Wave 2: 407), we identified 63 (16%) cases of PCC in Wave 1 and 81 (20%) in Wave 2. In Wave 1, common PCC symptoms included chest pain (14; 18%) and cough (11; 14%), while Wave 2 patients reported fatigue (16; 20%) and cough (16; 20%). Severe disease (aIRR = 2.0, 95%CI: 1.4–2.6) and any comorbidity (aIRR = 1.9, 95%CI: 1.2–2.8) during Wave 1 and any comorbidity (aIRR = 2.6, 95% CI 2.1–3.3) during Wave 2 were associated with PCC. Interpretation: Approximately 1 in 5 previously-hospitalized COVID-19 survivors experienced PCC during both waves, emphasizing the need for close follow-up and appropriate post-COVID-19 care.

Publisher

Research Square Platform LLC

Reference34 articles.

1. World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020 [Internet]. [cited 2023 Sep 26]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

2. Amin R, Sohrabi MR, Zali AR, Hannani K. Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome. BMC Infect Dis [Internet]. 2022 Dec 1 [cited 2023 Sep 26];22(1):1–10. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07909-y

3. Soriano V, Ganado-Pinilla P, Sanchez-Santos M, Gómez-Gallego F, Barreiro P, de Mendoza C, Corral O. Main differences between the first and second waves of COVID-19 in Madrid, Spain. Int J Infect Dis [Internet]. 2021 Apr 1 [cited 2023 Sep 26];105:374–6. Available from: http://www.ijidonline.com/article/S1201971221002010/fulltext

4. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples;Bullard J;Clin Infect Dis,2020

5. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study;Docherty AB;BMJ,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3